Genmab reported DKK662M in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US USD 36.53M 118.27M
Almirall ALM:SM EUR 13.9M 14.3M
Amarin AMRN:US USD -3883000 60.92M
Amgen AMGN:US USD 2.54B 364M
Argen X Bv ARGX:BB USD -41240000 199.78M
AstraZeneca AZN:LN USD 2.29B 796M
Biomarin Pharmaceutical BMRN:US USD -17558000 15.65M
Bluebird Bio BLUE:US USD -76513000 16.99M
Exelixis EXEL:US USD -31427000 123.47M
Fresenius Medical Care FME:GR EUR 390.62M 6.38M
Genmab GEN:DC DKK 662M 2.61B
GlaxoSmithKline GSK:LN GBP 1.36B 1.07B
GN Store Nord GN:DC DKK 354M 81M
Hikma Pharmaceutical HIK:LN USD 269M 18M
Immunogen IMGN:US USD -57790000 19.96M
Insmed INSM:US USD -159998000 29.22M
Lonza Group LONN:SW CHF 683M 36M
Novartis NOVN:VX USD 3.86B 195M
Regeneron Pharmaceuticals REGN:US USD 1.63B 188.9M
Roche Holding ROG:VX 8.85B 3.26B
Sanofi SAN:FP EUR 2.75B 1.68B
William Demant Holding WDH:DC DKK 1.43B 59M